Bizarre Patents
Ballistic resistant body covering
A ballistic resistant body covering for protecting the torso, groin and neck area from ballistic missiles.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8166970 | Inhalation apparatus An inhaler is instantly activated upon its removal from a cover or cover unit, and by rotating a cartridge component of the inhaler with respect to a mouthpiece portion, so as to create a flow pathway for ambient air and particles. The cartridge component includes a... | 05/01/2012 |
| 8163294 | Growth regulatable recombinant BCG compositions Immunogenic compositions comprising growth regulatable recombinant attenuated intracellular pathogens that have been transformed to express recombinant immunogenic antigens of the same or other intracellular pathogens are provided. Exemplary immunogenic compositions... | 04/24/2012 |
| 8156936 | Unit dose capsules and dry powder inhaler Described are dry powder inhalers comprising an intake section, a mixing section and a mouthpiece. The mixing section can accommodate a capsule having a top keying portion and containing a dry powder medicament. The top keying portion of the capsules may fit within ... | 04/17/2012 |
| 8154713 | Methods of determination of iron deficiency and hemochromatosis New diagnostic parameters or indexes for detection of absolute iron deficiency, latent iron deficiency, functional iron deficiency, or latent functional iron deficiency have been disclosed. The parameters include a RBC size factor, RSf1 defined by the for... | 04/10/2012 |
| 8154273 | Detecting and handling coincidence in particle analysis Methods and systems substantially eliminate data representative of coincident events from particle analyzer data. A fluid sample containing particles for analysis is prepared. Using an electrical or optical measurement device, signals are sensed. Each signal corresp... | 04/10/2012 |
| 8149041 | High-resolution parametric signal restoration Provided are high-resolution parametric signal restoration systems, and applications thereof. Such systems include a multi-output module and a parametric compensator. The multi-output module provides a reference gain output signal and one or more higher gain output ... | 04/03/2012 |
| 8148320 | Peptide inhibitors of ABL kinases Provided are purified compounds comprising SEQ ID NO:1, where the tyrosine at residue (10) is phosphorylated. Also provided are purified compounds comprising SEQ ID NO:1, where the amino acid sequence of the compound is less than 400 amino acids. Additionally provid... | 04/03/2012 |
| 8146625 | Fail-safe method and apparatus for aspirating and/or dispensing liquids in automated laboratory instruments A method for preventing either the introduction of air into a liquid aspirated from a container through an aspiration line passing through a container cap, or the over-filling or non-filling of a container by a liquid dispensed through a dispensing line passing thro... | 04/03/2012 |
| 8146588 | Unit dose capsules and dry powder inhaler Described are dry powder inhalers composing an intake section, a mixing section and a mouthpiece. The mixing section can accommodate a capsule having a top keying portion and containing a dry powder medicament. The top keying portion of the capsules may fit within c... | 04/03/2012 |
| 8137975 | Method for a rapid antibody-based analysis of platelet populations A method for identifying a platelet population, preferably a population of immature, reticulated platelets, in a biological sample involves incubating the biological sample for less than 5 minutes with at least one labeled, ligand (e.g., monoclonal antibody) that bi... | 03/20/2012 |
| 8133514 | Carbon-substituted diketopiperazine delivery systems Compositions useful in the delivery of active agents are provided. These delivery compositions include (a) an active agent; and (b) a carrier of at least one mono-C-substituted or di-C-substituted diketopiperazine. Methods for preparing these compositions and admini... | 03/13/2012 |
| 8124068 | Recombinant intracellular pathogen immunogenic compositions and methods of use Immunogenic compositions comprising recombinant attenuated intracellular pathogens that have been transformed to express recombinant immunogenic antigens of the same or other intracellular pathogens are provided. Exemplary immunogenic compositions include, but are n... | 02/28/2012 |
| 8119593 | Method of treating diabetes type 2 by metformin and an ultrarapid acting insulin Disclosed herein are improved methods of treating hyperglycemia with a combination of an ultrarapid acting insulin and insulin glargine comprising prandial administration of the ultrarapid insulin, and administration of a first dose of insulin glargine within 6 hour... | 02/21/2012 |
| 8119398 | Adipose-derived stem cells for tissue regeneration and wound healing Compositions and methods for promoting tissue regeneration, particularly skin regeneration, with adipose-derived stem cells are provided. Additionally methods and compositions for promoting tissue regeneration with adipose-derived stem cell side population cells are... | 02/21/2012 |
| 8110719 | ABI1 conditional knockout mouse Genetically engineered conditional knock-out mice having conditional disruption of the Abi1/Hssh3bp1 gene are disclosed along with methods of making and using same. ... | 02/07/2012 |
| 8110393 | Method and apparatus for separating and harvesting cells from a whole blood sample The present specification discloses an automated method and apparatus useful for separating and harvesting cells of interest, e.g., mononuclear cells, in a whole blood sample. The method of the invention uses the aspirating/dispensing probe of an automated sample pr... | 02/07/2012 |
| 8101662 | Treatment of cancer with specific RXR agonists A method of treating cancer is disclosed comprising administering to a patient in need of such treatment a RXR agonist at a level below the RAR activating threshold and at or above the RXR effective dose. ... | 01/24/2012 |
| 8094299 | Transducer module Transducer modules for use in a blood analysis instrument and methods for analyzing a blood sample. The transducer modules presented generally include a light source, a focus-alignment system, a flow cell, and a light scatter detection system. Electrodes within the ... | 01/10/2012 |
| 8063233 | Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives Methods for treating cognitive/attention deficit disorders in general using tetrahydroindolone derivatives and analogues, particularly tetrahydroindolone derivatives or analogues in which the tetrahydroindolone derivative or analogue is covalently linked to another ... | 11/22/2011 |
| 8039431 | Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent Methods are provided for drying a particle. Specifically, there is provided a spray-dried diketopiperazine-insulin particle formulation having improved aerodynamic performance and in which the active agent is more stabile and efficiently delivered as compared to tha... | 10/18/2011 |
| 8038638 | Plasma detoxification and volume control system and methods of use An extracorporeal circuit for removing toxins from the blood and plasma volume control in patients suffering from sepsis and renal failure. The extracorporeal circuit disclosed herein comprises a plasma filter, a toxin removal device and optionally a hemofilter that... | 10/18/2011 |
| 8030278 | Methods, compositions and articles of manufacture for contributing to the treatment of cancers Methods, compositions and articles of manufacture for contributing to the treatment of cancers, including solid tumors, are disclosed. The methods, compositions and articles of manufacture can utilize an endothelin B agonist (ETB) to enhance the delivery ... | 10/04/2011 |
| 8026216 | Methods and compositions for contributing to the treatment of cancers Methods and compositions for contributing to the treatment of cancers, especially ovarian tumors, are disclosed. The methods and compositions utilize an endothelin B agonist (ETB) to enhance the delivery and resulting efficacy of chemotherapeutic agent(s)... | 09/27/2011 |
| 8000940 | Shape parameter for hematology instruments Systems, methods, and computer program products are provided for describing characteristics of a data sample. This description is used to represent the shape of a histogram of the data sample. ... | 08/16/2011 |
| D643308 | Blister packaging | 08/16/2011 |
| 7977369 | Medical compositions for intravesical treatment of bladder cancer Methods for treating bladder cancer comprising intravesicular administration of a stabilized pharmaceutical formulation comprising 5-(1-aziridinyl)-3-(hydroxymethyl)-2-[(E)-3-hydroxyprop-1-enyl]-1-methyl-1H-indole-4,7-dione (EO9). More specifically, the stabilized p... | 07/12/2011 |
| 7976835 | Methods and compositions for preventing and treating solid tumors Compositions and methods of preventing or treating a breast cancer are disclosed. The composition and method can utilize an endothelin B agonist and a chemotherapeutic agent as active ingredients to treat a solid tumor in mammals, including humans. Alternatively, th... | 07/12/2011 |
| 7972301 | Safety needle syringe braking system A braking mechanism for a retractable safety syringe is disclosed herein. In a first embodiment, the braking mechanism is disposed about the distal end of a piston. The braking mechanism may comprise a friction material about a post attached to a piston. The frictio... | 07/05/2011 |
| 7972300 | Syringe A retractable needle safety syringe is provided having a braking mechanism. The braking mechanism may be disposed at a proximal portion of a syringe body of the syringe. The braking mechanism may comprise a brake member which is traversable between a braking positio... | 07/05/2011 |
| D640553 | Dispensing cap | 06/28/2011 |
| D640552 | Dispensing cap | 06/28/2011 |
| 7947468 | Methods A method for identifying a compound expected to be useful in modulating a LRRK2 protein kinase activity, the method comprising the steps of (1) determining whether a test compound modulates the protein kinase activity of a LRRK2 polypeptide on a substrate Ezrin/Radi... | 05/24/2011 |
| 7947020 | Retractable safety syringe A retractable safety syringe may have a ferrule and needle which are selectively removeable from a distal end of a syringe body. In particular, the ferrule may have an annular flange. A wedge element may be frictionally engaged to the ferrule and a distal end of the... | 05/24/2011 |
| 7943572 | Superior control of blood glucose in diabetes treatment Methods related to the treatment of diabetes and improving the control of blood glucose levels are provided. In particular, methods are provided for effectively reducing postprandial glucose excursions while reducing the incidence of clinically significant late post... | 05/17/2011 |
| 7943178 | Methods and compositions for delivering peptides Methods are provided for purifying peptides and proteins by incorporating the peptide or protein into a diketopiperazine or competitive complexing agent to facilitate removal one or more impurities, from the peptide or protein. Formulations and methods also are prov... | 05/17/2011 |
| D636869 | Dry powder inhaler | 04/26/2011 |
| D636868 | Dry powder inhaler | 04/26/2011 |
| D636867 | Dry powder inhaler | 04/26/2011 |
| 7928084 | Regulation of integrin surface expression Disclosed are methods and compositions for preventing and treating conditions associated with platelet aggregation, comprising administering a therapeutically effective amount of a composition that modifies the interaction of DNAJC10 with αIIbβ3 in a megakaryocyte... | 04/19/2011 |
| 7927580 | Tat-based immunomodulatory compositions and methods of their discovery and use A method for identifying new immunomodulatory chemical entities (NICE) comprising reacting a candidate NICE with a Tat SH3 binding domain, identifying the bound candidate NICE and determining whether the candidate NICE induces monocytes to differentiate into dendrit... | 04/19/2011 |
